EGFR and glioblastoma: With regard to genetic alterations, GBM is typically isocitrate dehydrogenase (IDH)-wild-type and has epidermal growth factor receptor (EGFR) amplification or mutations, phosphatase and tensin homolog (PTEN) deletion or mutations, and loss of heterozygosity on 10q [2].